A wave of empowerment swept through Seme as the Widows Empowerment Program delivered tangible hope and critical support to ...
Lake Street analyst Frank Takkinen reiterated a Buy rating on REPRO-MED Systems (KRMD – Research Report) today and set a price target of $6.00. The company’s shares closed last Friday at $2.28.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback